Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy

SIMPLE SUMMARY: Gastroenteropancreatic neuroendocrine neoplasms (GEP NENs) are a family of rare cancers with rising incidence in recent years. GEP NEN tumor cells are difficult to propagate, and few cellular and patient-derived xenograft (PDX) models are available for testing new therapies and study...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Catherine G., Borbon, Luis C., Mudd, Jacqueline L., Abusada, Ellen, AghaAmiri, Solmaz, Ghosh, Sukhen C., Vargas, Servando Hernandez, Li, Guiying, Beyer, Gabriella V., McDonough, Mary, Li, Rachel, Chan, Carlos H.F., Walsh, Susan A., Wadas, Thaddeus J., O’Dorisio, Thomas, O’Dorisio, M Sue, Govindan, Ramaswamy, Cliften, Paul F., Azhdarinia, Ali, Bellizzi, Andrew M., Fields, Ryan C., Howe, James R., Ear, Po Hien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033026/
https://www.ncbi.nlm.nih.gov/pubmed/35454817
http://dx.doi.org/10.3390/cancers14081910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033026/
https://www.ncbi.nlm.nih.gov/pubmed/35454817
http://dx.doi.org/10.3390/cancers14081910

Ejemplares similares